GMAB

#4257
Genmab A/S ADS
29.44
+2.12%
Setor:
Base:
Moeda do lucro:
Faixa diária
29.44
29.44
Faixa anual
17.23
35.43
Mudança diária
+2.12%
Mudança mensal
-10.84%
Mudança em 6 meses
+17.01%
Mudança anual
+30.15%
Fechamento anterior
28.83
Open
29.44
Bid
Ask
Low
29.44
High
29.44
Volume
48
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 3 029
  • Founded 1999
  • CEO Jan G. J. van de Winkel
  • Website www.genmab.com
  • Headquarter Denmark
  • FIGI BBG004MPKM64
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Genmab A/S - American Depositary Shares

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.

Notícias